{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:48:57Z","timestamp":1780516137996,"version":"3.54.1"},"reference-count":56,"publisher":"Impact Journals, LLC","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,13]]},"DOI":"10.18632\/oncotarget.5167","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"31767-31779","source":"Crossref","is-referenced-by-count":32,"title":["Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia"],"prefix":"10.18632","volume":"6","author":[{"given":"Siddhartha","family":"Ganguly","sequence":"first","affiliation":[{"name":"The University of Kansas Cancer Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Home","sequence":"additional","affiliation":[{"name":"The University of Kansas Cancer Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulraheem","family":"Yacoub","sequence":"additional","affiliation":[{"name":"The University of Kansas Cancer Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Kambhampati","sequence":"additional","affiliation":[{"name":"The University of Kansas Cancer Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidong","family":"Shi","sequence":"additional","affiliation":[{"name":"Georgia Regents University, Augusta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Dandawate","sequence":"additional","affiliation":[{"name":"The University of Kansas Cancer Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Padhye","sequence":"additional","affiliation":[{"name":"Interdisciplinary Science and Technology Research Academy, University of Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Saluja","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"McGuirk","sequence":"additional","affiliation":[{"name":"The University of Kansas Cancer Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Rao","sequence":"additional","affiliation":[{"name":"The University of Kansas Cancer Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2011-11-312421","article-title":"Risk categories and refractory CLL in the era of chemoimmunotherapy","volume":"119","author":"Stilgenbauer","year":"2012","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","article-title":"From pathogenesis to treatment of chronic lymphocytic leukaemia","volume":"10","author":"Stilgenbauer","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib","volume":"370","author":"Lozanski","year":"2014","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cancergen.2014.01.004","article-title":"Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants","volume":"207","author":"Kay","year":"2014","journal-title":"Cancer Genet"},{"key":"5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0165-4608(01)00665-3","article-title":"Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy","volume":"136","author":"Rasnick","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"6","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1101\/gad.207407.112","article-title":"Aneuploidy causes proteotoxic stress in yeast","volume":"26","author":"Amon","year":"2012","journal-title":"Genes Dev"},{"key":"7","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.15252\/embj.201488648","article-title":"HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells","volume":"33","author":"Storchova","year":"2014","journal-title":"EMBO J"},{"key":"8","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Khochbin","year":"2007","journal-title":"Genes Dev"},{"key":"9","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4161\/cc.5.22.3448","article-title":"Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties","volume":"5","author":"Kroemer","year":"2006","journal-title":"Cell Cycle"},{"key":"10","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1158\/0008-5472.CAN-05-3778","article-title":"Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma","volume":"66","author":"Garrido","year":"2006","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2012.06.031","article-title":"HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers","volume":"150","author":"Lindquist","year":"2012","journal-title":"Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tibs.2013.02.003","article-title":"The chaperone Hsp90: changing partners for demanding clients","volume":"38","author":"Buchner","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2011.01.017","article-title":"Identification of aneuploidy-selective antiproliferation compounds","volume":"144","author":"Amon","year":"2011","journal-title":"Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2003.12.005","article-title":"Altered states: selectively drugging the Hsp90 cancer chaperone","volume":"10","author":"Workman","year":"2004","journal-title":"Trends Mol Med"},{"key":"15","first-page":"1799","article-title":"Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts","volume":"61","author":"Bhalla","year":"2001","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nchembio.670","article-title":"Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90","volume":"7","author":"Alpaugh","year":"2011","journal-title":"Nat Chem Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.leu.2402257","article-title":"The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy","volume":"15","author":"Neckers","year":"2001","journal-title":"Leukemia"},{"key":"18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","article-title":"Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition","volume":"150","author":"Lindquist","year":"2012","journal-title":"Cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/onc.2008.380","article-title":"Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors","volume":"28","author":"Workman","year":"2009","journal-title":"Oncogene"},{"key":"20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1535-7163.MCT-07-0484","article-title":"A novel Hsp90 inhibitor to disrupt Hsp90\/Cdc37 complex against pancreatic cancer cells","volume":"7","author":"Sun","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2013-07-515361","article-title":"Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)","volume":"123","author":"Buggy","year":"2014","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Hamblin","year":"2003","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjh.12164","article-title":"The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma","volume":"160","author":"Chatterjee","year":"2013","journal-title":"Br J Haematol"},{"key":"24","doi-asserted-by":"crossref","first-page":"G948","DOI":"10.1152\/ajpgi.00346.2010","article-title":"Prosurvival role of heat shock factor 1 in the pathogenesis of pancreatobiliary tumors","volume":"300","author":"Saluja","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"25","first-page":"156","article-title":"A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Saluja","year":"2012","journal-title":"Sci Transl Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.canlet.2013.02.050","article-title":"Minnelide reduces tumor burden in preclinical models of osteosarcoma","volume":"335","author":"Subramanian","year":"2013","journal-title":"Cancer Lett"},{"key":"27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00280-014-2428-6","article-title":"Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102","volume":"73","author":"Andreeff","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.03.016","article-title":"Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway","volume":"348","author":"Saluja","year":"2014","journal-title":"Cancer Lett"},{"key":"29","doi-asserted-by":"crossref","first-page":"33927","DOI":"10.1074\/jbc.M113.500983","article-title":"Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1","volume":"288","author":"Saluja","year":"2013","journal-title":"J Biol Chem"},{"key":"30","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1053\/j.gastro.2009.01.070","article-title":"Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms","volume":"136","author":"Saluja","year":"2009","journal-title":"Gastroenterology"},{"key":"31","doi-asserted-by":"crossref","first-page":"G1011","DOI":"10.1152\/ajpgi.00466.2013","article-title":"Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells","volume":"306","author":"Saluja","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"32","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1471-4914(02)02316-X","article-title":"Hsp90 inhibitors as novel cancer chemotherapeutic agents","volume":"8","author":"Neckers","year":"2002","journal-title":"Trends Mol Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0145-2126(92)90008-U","article-title":"High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells","volume":"16","author":"Nawata","year":"1992","journal-title":"Leuk Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"e980","DOI":"10.1038\/cddis.2013.508","article-title":"HER2\/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer","volume":"5","author":"Moll","year":"2014","journal-title":"Cell Death Dis"},{"key":"35","doi-asserted-by":"crossref","first-page":"35646","DOI":"10.1074\/jbc.M112.377481","article-title":"Heat shock factor Hsf1 cooperates with ErbB2 (Her2\/Neu) protein to promote mammary tumorigenesis and metastasis","volume":"287","author":"Mivechi","year":"2012","journal-title":"J Biol Chem"},{"key":"36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1189\/jlb.0709502","article-title":"Differential heat shock protein localization in chronic lymphocytic leukemia","volume":"87","author":"Williams","year":"2010","journal-title":"J Leukoc Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tox.2009.10.023","article-title":"Triptolide alters histone H3K9 and H3K27 methylation state and induces G0\/G1 arrest and caspase-dependent apoptosis in multiple myeloma","volume":"267","author":"Zhang","year":"2010","journal-title":"Toxicology"},{"key":"38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbamcr.2011.09.003","article-title":"The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones","volume":"1823","author":"Buchner","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"39","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1074\/jbc.M806715200","article-title":"The human Cdc37. Hsp90 complex studied by heteronuclear NMR spectroscopy","volume":"284","author":"Schwalbe","year":"2009","journal-title":"J Biol Chem"},{"key":"40","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1158\/0008-5472.CAN-08-0644","article-title":"Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion","volume":"68","author":"Bhalla","year":"2008","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molcel.2006.12.008","article-title":"An acetylation site in the middle domain of Hsp90 regulates chaperone function","volume":"25","author":"Neckers","year":"2007","journal-title":"Mol Cell"},{"key":"42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone- dependent activation of glucocorticoid receptor","volume":"18","author":"Yao","year":"2005","journal-title":"Mol Cell"},{"key":"43","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2008-03-143644","article-title":"HDAC6 inhibition enhances 17-AAG\u2014mediated abrogation of hsp90 chaperone function in human leukemia cells","volume":"112","author":"Bhalla","year":"2008","journal-title":"Blood"},{"key":"44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Pelicci","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","article-title":"Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor","volume":"17","author":"Marmorstein","year":"2010","journal-title":"Chem Biol"},{"key":"46","doi-asserted-by":"crossref","first-page":"e55481","DOI":"10.1371\/journal.pone.0055481","article-title":"A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"47","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1182\/blood-2009-05-223586","article-title":"A novel Rag2\u2212\/\u2212gammac-\/\u2014xenograft model of human CLL","volume":"115","author":"Ghia","year":"2010","journal-title":"Blood"},{"key":"48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbamcr.2011.07.018","article-title":"Post-translational modifications of Hsp90 and their contributions to chaperone regulation","volume":"1823","author":"Neckers","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.molcel.2012.05.015","article-title":"Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine","volume":"47","author":"Neckers","year":"2012","journal-title":"Mol Cell"},{"key":"50","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1002\/anie.200900929","article-title":"Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol","volume":"48","author":"Schwalbe","year":"2009","journal-title":"Angew Chem Int Ed Engl"},{"key":"51","doi-asserted-by":"crossref","first-page":"56053","DOI":"10.1074\/jbc.M409267200","article-title":"Celastrols as inducers of the heat shock response and cytoprotection","volume":"279","author":"Morimoto","year":"2004","journal-title":"J Biol Chem"},{"key":"52","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1158\/1535-7163.MCT-12-1231","article-title":"Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation","volume":"12","author":"Saluja","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4161\/epi.20237","article-title":"Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia","volume":"7","author":"Munn","year":"2012","journal-title":"Epigenetics"},{"key":"54","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","article-title":"Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia","volume":"74","author":"Wiestner","year":"2014","journal-title":"Cancer Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/1535-7163.MCT-11-0979","article-title":"Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells","volume":"11","author":"Bhalla","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"56","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s11095-012-0700-1","article-title":"Inclusion complex of novel curcumin analogue CDF and beta-cyclodextrin (1:2) and its enhancedanticancer activity against pancreatic cancer","volume":"29","author":"Sarkar","year":"2012","journal-title":"Pharm Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T16:47:38Z","timestamp":1589388458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,10]]},"references-count":56,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,10,13]]}},"alternative-id":["5167","26397138"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5167","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,10]]}}}